Vcanbio Cell&Gene Engineering Corp.,Ltd’s Net Profit Dropped 2.7% in First Quarter of 2023

Vcanbio Cell&Gene Engineering Corp.,Ltd (中源协和细胞基因工程股份有限公司) (600645.SH) reported a net profit of 35.3 million yuan in the first quarter of 2023, down 2.7% year-on-year.

Meanwhile, the company posted 377.7 million yuan in revenue, down 4.2% year-on-year.

At the end of the reporting period, it had 5.2 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 30%.